CHARLOTTE, North Carolina, April 16 /PRNewswire/ --

- National Health Service hospitals' usage by stroke rehab patients dictates increase in staff and Saebo-trained therapists

Saebo, Inc. announced in its first quarter that its subsidiary, Saebo UK, Ltd., had another record year in 2008 and has added staff to accommodate its continued impressive growth in 2009.

BERLIN, Germany, April 16 /PRNewswire/ --

- Problem Likely to Expand to Developed Countries

- Agricultural Productivity Growth Declining

- Governments and Businesses Need to Urgently Invest in Agriculture

In response to the threat of global malnutrition and food insecurity, the recently established Humboldt Forum for Food and Agriculture has urged the immediate adoption of a five-point plan of action, entitled Food First.

NEW YORK, April 16 /PRNewswire/ --

- New Executive Will Help Drive Company's Continued Aggressive Growth Strategy

Teliris, the leading provider of immersive telepresence and immersive collaboration solutions, today announced the appointment of Rick Glickman as Chief Financial Officer to strengthen and expand Teliris' executive management team as it continues the execution of its aggressive growth strategy.

Glickman will lead the company in financial and legal affairs and brings more than 25 years of experience in expanding high-growth companies, with significant expertise in revenue growth, budgeting/forecasting, tax and audit issues as well as international management.

ST. LOUIS, Missouri, April 16 /PRNewswire/ -- Elsevier and the American College of Cardiology announced today that JACC: Cardiovascular Imaging (http://www.elsevier.com/locate/jacima) (ISSN: 1936-878X) and JACC: Cardiovascular Interventions (http://www.elsevier.com/locate/JACINT) (ISSN: 1936-8798) have been selected for coverage in MEDLINE. Maintained by the U.S. National Library of Medicine(R), MEDLINE (Medical Literature Analysis and Retrieval System Online) is a premier bibliographic database containing approximately 13 million references to journal articles in life sciences.

RALEIGH, North Carolina, April 16 /PRNewswire/ --

- Interactive workshops to exchange ideas with experts on clinical development: Copenhagen and Munich

PRA International, a leading Clinical Research Organization, will host two interactive workshops on how to manage the challenges posed by current market conditions, improve planning for successful trials and marketing approvals, and increase efficiency working with different vendors throughout the development process. The first workshop will take place in Munich on April 21, 2009; the second workshop will occur on April 23, 2009 in Copenhagen.

PALO ALTO, California, April 16 /PRNewswire/ --

Cell Biosciences, Inc., a provider of nanoproteomic analysis systems to life science researchers, today announced the launch of the Cell Biosciences CB1000 protein analysis system, a next-generation platform for ultrasensitive characterization of cell signaling proteins. The CB1000 establishes a new standard for sensitivity, reproducibility, and ease-of-use for researchers studying signaling pathways in limited samples, such as small tumor biopsies and stem cells. The CB1000 will be unveiled at the American Association for Cancer Research (AACR) 100th Annual Meeting, April 18-22, 2009, in Denver, Colorado (booth 2039).

SAN JOSE, California, April 16 /PRNewswire/ --

LONDON, April 16 /PRNewswire/ --

Cascal N.V. (NYSE: HOO) (the Company), a leading provider of water and wastewater services in seven countries, today announced that its subsidiary, Bournemouth West Hampshire Water (BWHW), was awarded the Charter Mark for excellence in public services for the tenth successive year, and received a certificate of recognition for successfully keeping the Investor in People standard for more than a decade. In addition, BWHW was named the sixth most efficient water company out of 21 by OFWAT, the economic regulator for the water industry in England and Wales.

LONDON, April 16 /PRNewswire/ -- Pharmaceutical companies GlaxoSmithKline and Pfizer today announced an innovative agreement to pool their HIV assets creating a new world-leading, specialist HIV company.

The deal will see the drug giants combine their existing HIV product and their pipelines with GSK holding 85% of the company and Pfizer 15%.

The deal will be marginally dilutive to GSK earnings in the first two years but in a video interview Group CEO Andrew Witty said there were longer term benefits for GSK shareholders.

Today we own 100 per cent of a pipeline with three assets in it. Tomorrow we'll own 85 per cent of a pipeline with somewhere between five and seven assets in it.

LONDON, April 16 /PRNewswire/ --

- Leading International Collaboration Adds Email to Music, Gaming and Maps for the Ultimate Mobile Multimedia Experience

Orange and Nokia today announced they will extend their partnership with a new, simple-to-use email service for consumers. This extension to their multi-country agreement will deliver and launch a co-branded solution, Nokia Messaging by Orange, on a range of Orange Signature devices, aiming to bring mobile email to everyone with a phone, as well as working professionals.